4588.T
Oncolys BioPharma Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 7,400.00
−6.33%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- —
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | — | -JPY 12 | — | JPY 500.0M |
| May 8, 2026 | — | -JPY 14 | — | JPY 3.0M |
| Nov 7, 2025 | — | -JPY 12 | — | — |
| Aug 8, 2025 | — | -JPY 20 | — | JPY 28.5M |
| May 9, 2025 | — | -JPY 33 | — | — |
| Feb 7, 2025 | — | -JPY 18 | — | — |
| Nov 8, 2024 | — | -JPY 22 | — | — |
| Aug 9, 2024 | — | -JPY 19 | — | JPY 31.4M |
| May 10, 2024 | — | -JPY 18 | — | — |
| Feb 9, 2024 | — | -JPY 35 | — | — |
| Nov 10, 2023 | — | -JPY 23 | — | — |
| Aug 4, 2023 | — | -JPY 31 | — | JPY 28.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026